(Q49082173)

English

High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index.

scientific article published on 2 May 2015

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

5

object named as

Ylermi Soini

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

author name string

Milla Elvi Linnea Kuusisto

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Kirsi-Maria Haapasaari

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Taina Turpeenniemi-Hujanen

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Esa Jantunen

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Pekka Peroja

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Risto Bloigu

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Peeter Karihtala

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Outi Kuittinen

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

language of work or name

0 references

publication date

2 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

68

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

552-556

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Peroxiredoxin 6 gene-targeted mice show increased lung injury with paraquat-induced oxidative stress

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Lung tumor growth-promoting function of peroxiredoxin 6.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Peroxiredoxins, a novel target in cancer radiotherapy

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Protein and miRNA profiling of radiation-induced skin injury in rats: the protective role of peroxiredoxin-6 against ionizing radiation

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Tumor-targeted induction of oxystress for cancer therapy

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Are peroxiredoxins tumor suppressors?

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202771

21 January 2018

Identifiers

10.1136/JCLINPATH-2014-202771

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/25935550

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49082173&oldid=1527278929"